FANCF and cervical cancer: Given that the Fanconi anemia complementation group F (FANCF) gene is disrupted in most cervical cancers, Narayan et al. proved that trichostatin A may induce its re-expression in cervical cancer cell lines, hence counteracting their chromosomal hypersensitivity phenotypes after exposure to alkylating agents [47].